Frank Groenewegen
InvestorManaging Director at 415 Capital
Germany
Writes $100K – $5M checks · typically $1.5M
About
Frank Groenewegen is a Co-Founder and Chairman Emeritus of 415C, with nearly 40 years of experience in medical technology, including 30 years as an investor and entrepreneur. He has funded over 40 companies and founded and exited several European medical device distribution companies, including CoRRect Medical (acquired by Uniphar PLC in 2021), Regis Medical GmbH, Ovum Ventures GmbH, and Cardiologic GmbH (acquired by Boston Scientific in 2002). He previously served as General Manager of Boston Scientific's Interventional Cardiology Division Germany and held management roles at St. Jude Medical, W. L. Gore & Associates, and American Hospital Supply Corp.
Invests in
Medical Devices
Colleagues at 415 Capital
Network5
Investors connected to Frank in public investor directories — a warm-intro map.